TFE3-REARRANGED RENAL CELL CARCINOMA

Clinical trials for TFE3-REARRANGED RENAL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new TFE3-REARRANGED RENAL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for TFE3-REARRANGED RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo tested in fight against rare, aggressive kidney cancer

Disease control Ongoing

This study is testing whether combining two cancer drugs works better than using just one to treat an aggressive form of kidney cancer that has spread or cannot be removed by surgery. The trial is enrolling patients of all ages, from children to adults. Researchers want to see if…

Matched conditions: TFE3-REARRANGED RENAL CELL CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

TFE3-REARRANGED RENAL CELL CARCINOMA

Get alerted when new TFE3-REARRANGED RENAL CELL CARCINOMA trials appear

New drug duo tested in fight against rare, aggressive kidney cancer